Electronic Arts Inc. vs Sana Biotechnology Inc — how do they compare? Electronic Arts Inc. trades at $207.31 (market cap $51.97B), while Sana Biotechnology Inc trades at $3.45 (market cap $987.94M). The key difference: Electronic Arts Inc. is far larger — about 52.6× Sana Biotechnology Inc's market cap, and Electronic Arts Inc. pays a 0.37% dividend while Sana Biotechnology Inc pays none. Which is the better fit depends on your goals.
| EA | SANA | |
|---|---|---|
Market Cap | $51.97B | $987.94M |
Sector | Technology | Health |
52-Week High | $207.27 | $5.92 |
52-Week Low | $147.79 | $2.68 |
Enterprise Value | $50.54B | $962.13M |
Dividend Yield | 0.37% | — |
Signals from Pluang's Aura AI — not financial advice
Electronic Arts (EA) trades at $206.65, showing modest daily gains of 0.15%. The stock exhibits a bullish technical structure with moving averages aligned positively, though oscillators signal caution with RSI levels above 70. Fundamentally, EA maintains strong profitability with 78.97% gross margins and 11.78% net income margins, but valuation metrics appear elevated with a P/E of 59.05 and P/S of 6.96. Recent business developments include the successful launch of EA SPORTS College Football 27 and the introduction of EA Advertising platform for in-game brand integration.
The outlook balances strong franchise execution against valuation concerns. Investment opportunities stem from EA's dominant gaming portfolio, recurring revenue streams, and new advertising monetization. Key risks include recent earnings misses, potential regulatory scrutiny of the rumored $55 billion Saudi acquisition (Reuters, June 24, 2026), and stretched valuation multiples that may limit near-term upside despite analyst consensus leaning positive.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
EA is one of the world's largest third-party video game publishers and has transitioned from a console-based video game publisher to the one of the largest publishers on consoles, PC, and mobile. The firm owns number of large franchises, including Madden, FIFA, Battlefield, Apex Legends, Mass Effect, Dragon's Age, and Need for Speed.
Read more on EA →Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.
Read more on SANA →